A phase IB study evaluating the safety and clinical activity of atezolizumab combined with obinutuzumab in patients with relapsed or refractory non-Hodgkin lymphoma Meeting Abstract
| Authors: | Palomba, M. L.; Till, B. G.; Park, S. I.; Morschhauser, F.; Cartron, G.; Marks, R.; Penuel, E.; Chitra, S.; Byon, J. C. H.; Popplewell, L. |
| Abstract Title: | A phase IB study evaluating the safety and clinical activity of atezolizumab combined with obinutuzumab in patients with relapsed or refractory non-Hodgkin lymphoma |
| Meeting Title: | 21st Congress of the European Hematology Association (EHA) |
| Journal Title: | Haematologica |
| Volume: | 101 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2016 Jun 9-12 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2016-06-01 |
| Start Page: | 102 |
| Language: | English |
| ACCESSION: | WOS:000379484600220 |
| PROVIDER: | wos |
| PMCID: | PMC4894295 |
| Notes: | Meeting Abstract: P314 -- Source: Wos |
MSK Authors
-
415Palomba